Tavo Biotherapeutics
United States · $17.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $17.0M
- Last Round
- $17.0M Series AJun 2026
- Rounds
- 1
About
Biotech company developing novel therapeutics for glaucoma and retinal disease, focused on breakthrough innovation to save vision.
Summary
Tavo Biotherapeutics is a Biotech company based in United States. It has raised $17.0M in total across 1 round, most recently a $17.0M Series A round in Jun 2026. Investors include Polaris Partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2026
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...